COVAX Current Affairs, GK & News

China’s vaccine makers sign COVAX agreements

Two major COVID-19 vaccine makers of China have signed agreements to provide 550 million doses to COVAX facility. Highlights Gavi announced to buy 110 million doses from Sinopharm and Sinovac between July and October 2021. It will buy 440 million more doses by mid-2022. These vaccines were approved by World Health Organization for emergency use. ..

Month: 

Category: 

Topics: 

G-7 plans 1 billion extra Covid-19 shots by 2022

Group of Seven (G-7) leaders are set to vow to deliver 1 billion extra doses of vaccines by 2022 to cover 80 percent of world’s adult population. Highlights Ahead of G-7 summit in UK, officials put together document outlining a plan to end pandemic by December 2022. Document is yet to be finalised but it ..

Month: 

Category: 

Topics: 

US announces 500 Million Vaccine doses to Poor Countries

United States President Joe Biden has announced to donate 500 million doses of Pfizer COVID-19 vaccine to poorest countries across world to end the pandemic as soon as possible. Key Points This donation is a bold move which showed, US recognises its responsibility towards world as well as its citizens. US will provide these half ..

Month: 

Category: 

Topics: 

IMF Proposes USD 50 Billion Global Vaccination Plan

The IMF (International Monetary Fund) proposed a USD 50 billion global vaccination plan which will cover about 40 percent of global population by the end of 2021. It also seeks to cover at least 60 percent of the population by first half of 2022. Key Points This plan was proposed on the line of work ..

Month: 

Category: 

Topics: 

Punjab to join COVAX facility

The Punjab Government recently announced that it is to join COVAX facility in order to increase its COVID-19 supplies. Why is Punjab joining COVAX facility? There is a huge vaccine shortage in India. This is slowing the vaccination efforts of the country. Thus the State Government of Punjab is planning to join COVAX facility. What ..

Month: 

Category: 

Topics: